Viome Life Sciences announced it closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million. Bold Capital and Khosla Ventures participated in the round ...

Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening ...

Viome Life Sciences, a biotechnology company, received $86.5 million in an oversubscribed Series C funding round, which it will use to grow its business, the company announced Friday. The Bellevue, ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...

LOS ANGELES, CA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Dentulu, the nation’s leading Teledentistry platform and pioneer of innovative at-home ...

Viome Life Sciences has snatched up Naring Health to build out its personalized nutrition offerings and further its goal to bring at-home diagnostics to the masses. The acquisition of digital health ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...